DK145276A - Erythromycinderivater og fremgangsmade til deres fremstilling - Google Patents

Erythromycinderivater og fremgangsmade til deres fremstilling

Info

Publication number
DK145276A
DK145276A DK145276A DK145276A DK145276A DK 145276 A DK145276 A DK 145276A DK 145276 A DK145276 A DK 145276A DK 145276 A DK145276 A DK 145276A DK 145276 A DK145276 A DK 145276A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
erythromycin derivatives
erythromycin
derivatives
Prior art date
Application number
DK145276A
Other languages
English (en)
Other versions
DK138656B (da
DK138656C (da
Inventor
R Maier
E Woitun
B Wetzel
H Goeth
W Reuter
U Lechner
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK145276(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK145276A publication Critical patent/DK145276A/da
Publication of DK138656B publication Critical patent/DK138656B/da
Application granted granted Critical
Publication of DK138656C publication Critical patent/DK138656C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK145276A 1975-04-07 1976-03-30 Analogifremgangsmaade til fremstilling af erythromycinderivater eller syreadditionssalte deraf DK138656C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
DK145276A true DK145276A (da) 1976-10-08
DK138656B DK138656B (da) 1978-10-09
DK138656C DK138656C (da) 1979-04-02

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK145276A DK138656C (da) 1975-04-07 1976-03-30 Analogifremgangsmaade til fremstilling af erythromycinderivater eller syreadditionssalte deraf

Country Status (29)

Country Link
US (1) US4048306A (da)
JP (1) JPS51128991A (da)
AT (1) AT342770B (da)
AU (1) AU498418B2 (da)
BG (1) BG27380A3 (da)
CA (1) CA1060005A (da)
CH (2) CH621800A5 (da)
CS (1) CS196304B2 (da)
DD (1) DD125218A5 (da)
DK (1) DK138656C (da)
ES (2) ES446737A1 (da)
FI (1) FI63244C (da)
FR (1) FR2306703A1 (da)
GB (1) GB1520963A (da)
GR (1) GR60374B (da)
HU (1) HU175186B (da)
IE (1) IE43598B1 (da)
IL (1) IL49359A (da)
LU (2) LU74702A1 (da)
MX (1) MX3277E (da)
NL (1) NL180107C (da)
NO (1) NO141411C (da)
NZ (1) NZ180529A (da)
PL (1) PL101880B1 (da)
PT (1) PT64977B (da)
RO (1) RO68441B (da)
SE (1) SE425566B (da)
SU (1) SU682134A3 (da)
YU (1) YU87676A (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860655B (en) 1985-03-12 1986-07-11 Beecham Group Plc Chemical compounds
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
CA2096969C (en) * 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
CZ281664B6 (cs) * 1991-09-30 1996-12-11 Eli Lilly And Company Patent Division Lilly Corporate Center Způsob jednostupňové přípravy dirithromycinu
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
WO1999021867A1 (fr) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1771158A4 (en) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSED DELIVERY
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
AU1272276A (en) 1977-10-13
NO141411B (no) 1979-11-26
IL49359A0 (en) 1976-06-30
DD125218A5 (de) 1977-04-06
AU498418B2 (en) 1979-03-15
HU175186B (hu) 1980-05-28
AT342770B (de) 1978-04-25
YU87676A (en) 1982-08-31
NO141411C (no) 1980-03-05
FI760845A (da) 1976-10-08
GB1520963A (en) 1978-08-09
JPS62158B2 (da) 1987-01-06
CH621800A5 (da) 1981-02-27
NL7603569A (nl) 1976-10-11
FR2306703B1 (da) 1979-10-12
RO68441A (ro) 1983-04-29
DK138656B (da) 1978-10-09
ATA149976A (de) 1977-08-15
DK138656C (da) 1979-04-02
ES456567A1 (es) 1978-03-01
PT64977B (de) 1978-04-03
JPS51128991A (en) 1976-11-10
CA1060005A (en) 1979-08-07
NL180107C (nl) 1987-01-02
MX3277E (es) 1980-08-15
FR2306703A1 (fr) 1976-11-05
US4048306A (en) 1977-09-13
BG27380A3 (en) 1979-10-12
CH624413A5 (da) 1981-07-31
IE43598L (en) 1976-10-07
LU88563I2 (fr) 1995-03-21
NL180107B (nl) 1986-08-01
CS196304B2 (en) 1980-03-31
PT64977A (de) 1976-05-01
LU74702A1 (da) 1977-06-03
RO68441B (ro) 1983-04-30
FI63244C (fi) 1983-05-10
SU682134A3 (ru) 1979-08-25
NZ180529A (en) 1978-09-20
NO761172L (da) 1976-10-08
SE7604052L (sv) 1976-10-08
FI63244B (fi) 1983-01-31
SE425566B (sv) 1982-10-11
ES446737A1 (es) 1977-10-16
IL49359A (en) 1979-07-25
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
PL101880B1 (pl) 1979-02-28

Similar Documents

Publication Publication Date Title
DK145276A (da) Erythromycinderivater og fremgangsmade til deres fremstilling
DK495476A (da) Phenolethere og fremgangsmade til deres fremstilling
DK563776A (da) Blegemidler og fremgangsmade til deres fremstilling
DK297076A (da) Phenyleddikesyrederivater og fremgangsmade til deres fremstilling
NO781130L (no) Cephemderivater og fremgangsmaate til deres fremstilling
DK299676A (da) Polyestere og fremgangsmader til deres fremstilling og anvendelse
DK189676A (da) Anti-tumor glycosider og fremgangsmade til disses fremstilling
DK552476A (da) Glucosaminderivater og fremgangsmade til fremstilling deraf
DK557876A (da) Polyhalogensteroider og fremgangsmade til deres fremstilling
DK148576A (da) Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
NO783471L (no) Xantinderivater og fremgangsmaate til deres fremstilling
DK522578A (da) G prostacyklinderivater og fremgangsmaade til deres fremstillin
DK412376A (da) Phenoxyalkylcarbonsyrer og fremgangsmade til deres fremstilling
DK340476A (da) Thiazolidinderivater og fremgangsmade til deres fremstilling
DK31576A (da) Acetylenderivater og fremgangsmade til deres fremstilling
DK582578A (da) 2,4-thiazolidindion-derivater og fremgangsmaade til deres fremstilling
DK308878A (da) Aminoglyosidderivater og fremgangsmaader til deres fremstilling
DK341576A (da) Homophthalimider og fremgangsmade til deres fremstilling
DK270077A (da) 6,7-benzomorphanderivater og fremgangsmade til deres fremstillling
DK161377A (da) Naphtyridinderivater og fremgangsmade til deres fremstilling
DK555176A (da) Sekundere etheraminer og fremgangsmade til deres fremstilling
DK223376A (da) N-benzyl-2,2-dimethoxy-acetamider og fremgangsmade til deres fremstilling
DK416278A (da) 2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK334079A (da) Anthraquinon-derivater og fremgangsmaade til deres fremstilling
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling

Legal Events

Date Code Title Description
PBP Patent lapsed
PUP Patent expired